about
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression.Perspective in infertility: the ovarian stem cells.Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells.Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA)PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression.Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells.pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.Constitutive down-regulation of Osterix in osteoblasts from myeloma patients: in vitro effect of Bortezomib and Lenalidomide.Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection.Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.Serum elevations of soluble Fas (CD95/apo-I) concur in deregulating T cell apoptosis during active lupus disease.Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells.Molecular specificities of CD4+ T cell-reactive IgM in human immunodeficiency virus (HIV-1) infection.In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization.Osteoclast-like cell formation by circulating myeloma B lymphocytes: role of RANK-L.Functional expression of the calcitonin receptor by human T and B cells.Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation.LFA-1 expression on CD4(+)CD45RO(+) peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a.Characterization of a rare nonpathogenic sequence variant (c.1905C>T) of the dihydropyrimidine dehydrogenase gene (DPYD).Functional osteoclast-like transformation of cultured human myeloma cell lines.Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncologyExpression and function of the calcitonin receptor by myeloma cells in their osteoclast-like activity in vitroImpaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cellsEnhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupusUpregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone diseaseCD8+/CD57+cells and apoptosis suppress T-cell functions in multiple myelomaFas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cellsFunctional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopeniaIgG M-components in active myeloma patients induce a down-regulation of natural killer cell activityOverexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosisTh1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12Reply: Improved understanding of very small embryonic-like stem cells in adult mammalian ovaryDissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancerAnimal-type melanoma: dog or wolf? A review of the literature and a case reportIn Vitro Generation of Oocytes from Ovarian Stem Cells (OSCs): In Search of Major Evidence
P50
Q32061748-4E386AB9-7161-402D-9B49-69B7F04C9036Q35927513-17A5C245-CB29-4F26-A0B2-680B3F7E8D8BQ38360350-A032B6C0-7E36-4666-87FF-D0B6E9D61C96Q38697843-7200B741-90BA-4B45-99DF-E6232409D7EBQ38705941-C5589BC3-A63B-42D2-B07A-942C085E2286Q39137073-5A03F443-BDB0-455A-B7DF-65137BB14F29Q40147550-909B0428-0B42-47BB-BCBA-A87B1970F286Q42368100-F5BA2278-9939-4A05-A776-8CFB529F162EQ43298203-6493E818-7E09-49A3-A179-E510C3A61C7BQ43683383-F83332EF-1317-4B7A-A50A-07F187C7C4A4Q43878419-973AB184-5479-4644-957C-B2E7BCB3ED88Q44017343-52ED7673-92B1-4F60-AA59-3740DA3B34CCQ45261087-BBB1F74C-B7C5-4DB8-82AC-B8F4631C58DEQ45783404-76EFB873-485E-4471-BDC7-75105ECBA3DAQ47205329-6717B616-6317-4F2F-9796-B203039E1690Q47722850-39AC1D0D-9FE1-454E-85DC-A52F0EA91D18Q47790832-EF61C268-E9F0-478D-A335-2A4057D24B1FQ51063770-9201DC0D-9E5C-450E-898C-01C605E06389Q52019189-D469FB29-8DCF-42D1-A92F-0F51DDE12737Q54409399-317B7854-DCA7-4A24-8191-11F8CFC918F2Q54644133-8646B8C4-EF04-41BE-ACEB-FCCE7BB89362Q58695249-5511FFB8-4B44-428C-B7AA-3034EFD86E13Q62071795-DC950056-FB74-46B6-AA25-F997EEC391E6Q62071796-CD37D863-A9D7-4A0B-BE21-B0A10E4B7014Q62071797-4F21B326-43F8-4BD3-80D4-4C551028A80DQ62071798-AB51BFDE-5FC3-4E55-9AFA-B00DB465E47CQ62071804-F40D4EC7-1C46-40EC-B5FE-2B58E9958576Q62071806-42942CEB-73D0-4E25-8F0E-26D17490A58FQ62071807-8AF890AE-D091-4550-8020-D8F1D24DCC25Q62071809-945FB7DD-0697-463D-A95C-661DD6FD7FEFQ62071812-CBA50F59-6D1A-4FA8-A064-C30FF96C9227Q73065165-FBB7D66B-E2EB-4A6A-98EC-4E5AC4C0D757Q87861015-4A4BA9F3-53A4-4BB1-B190-8F317924A705Q91386379-5802C9CA-BB75-40EF-AF96-F0063181206FQ91390736-DA96F6D4-1207-486B-B252-13FCD5642774Q91964262-E20FCAC2-BD6F-4A36-8D47-828760D7119C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paola Cafforio
@ast
Paola Cafforio
@en
Paola Cafforio
@es
Paola Cafforio
@nl
Paola Cafforio
@sl
type
label
Paola Cafforio
@ast
Paola Cafforio
@en
Paola Cafforio
@es
Paola Cafforio
@nl
Paola Cafforio
@sl
prefLabel
Paola Cafforio
@ast
Paola Cafforio
@en
Paola Cafforio
@es
Paola Cafforio
@nl
Paola Cafforio
@sl
P106
P1153
6701498420
P21
P31
P496
0000-0002-6940-8472